What Actually Makes a Probiotic Work

The probiotic aisle at any health-food store presents a confusing array of bottles, most labeled with billions of CFUs and one or two strain names. The unstated assumption is that strain count and CFU count are what matter — pick the bottle with bigger numbers, and you have a better product.

Scimera founder Dr. Fred Chaleff, an interventional cardiologist, takes a different position. On a recent appearance on the Fast Talk Labs podcast, he framed the question this way:

"There’s a thousand strains in your gut. Thirty to 40 are the most common. Why are you gonna take a probiotic that has one strain or two strains? And who even knows what amounts of those strains they have? It doesn’t do anything."

The problem with most probiotics on the market is not that they contain bad ingredients. It is that they contain a tiny, arbitrary subset of an ecosystem that requires diversity to function.

Four things a probiotic actually has to get right

Strain diversity that mirrors the gut. The human gut hosts 30 to 40 dominant bacterial strains. A probiotic with two of them is not seeding an ecosystem; it is dropping two species into a community that needs dozens of partners to work. Look for products formulated around the most-prevalent strains, not whatever is easiest to manufacture at scale.

The right balance of aerobic and anaerobic species. A healthy gut contains both bacteria that need oxygen and bacteria that thrive without it. The byproducts of one feed the other. Most off-the-shelf probiotics are dominated by aerobic Lactobacillus species because they are easier to grow and stabilize. A probiotic that emulates the gut’s actual ratios includes anaerobic species like Bifidobacterium, which are harder to formulate but more representative of what should be there.

A yeast component. The gut microbiome is not just bacteria. Saccharomyces boulardii, a beneficial yeast, is part of the symbiotic environment in healthy guts and has its own clinical literature behind it — particularly for protecting the gut during antibiotic use. Probiotics that exclude yeast are leaving out part of the system.

Delivery that survives stomach acid. Stomach acid is designed to kill ingested microorganisms. A probiotic capsule that releases its contents in the stomach delivers a dead population to your duodenum. Delayed-release formulations — capsules engineered to open further down the digestive tract — make a meaningful difference in how much of the active material actually reaches the small intestine alive.

A prebiotic to feed what arrives. Probiotic bacteria need a food source the moment they reach the gut, particularly the indigestible fiber components (prebiotics) that they ferment into short-chain fatty acids. A probiotic without a prebiotic is dropping passengers into a city without giving them a meal.

Does this matter outside of clinical settings?

The clinical literature on properly-formulated probiotics is more compelling than the marketing for most products would suggest. In one cited trial, marathon runners who took a multi-strain probiotic for 28 days before a race reported significantly lower incidence and severity of gastrointestinal symptoms during the race itself, and a smaller drop in average pace, compared to a placebo group.

For people training at lower volumes, the everyday case is subtler — better consistency in digestion, fewer bouts of low energy, and faster recovery from the kind of upper respiratory irritation discussed in our previous post.

Where Scimera fits in

Scimera’s probiotic was developed around exactly these criteria: 18 strains drawn from the most common species in the human gut, formulated in a delayed-release capsule with a balance of aerobic and anaerobic bacteria plus Saccharomyces boulardii. Those decisions were made because the research said they mattered.

The general lesson is the same regardless of which product you choose: read past the front of the label. The number of CFUs is not the question. The question is what is in there, in what ratios, and whether the capsule survives long enough to deliver it.

 

This post draws on a conversation between Scimera founder Dr. Fred Chaleff, host Trevor Connor, and co-host Chris Case on the Fast Talk Labs podcast. Listen to the full episode: The Critical Roles of Inflammation, the Immune System, and the Gut in Performance.